Wize Pharma, Inc. (32) | Intellectual Property (2)
- Exclusive License Agreement (the License Agreement) with Copernicus Therapeutics, Inc (Filed With SEC on November 14, 2019)
- Amendment to License Agreement with Resdevco Research and Development Company Ltd (Filed With SEC on November 14, 2019)